JAVASCRIPT DISABLED


Note: Our system indicates that Javascript is disabled or not supported by your browser.
Javascript must be enabled in order to use this site. Please enable Javascript in your browser and try again.

EpiPen Adrenaline Auto-Injector Shortages in the UK
  Loading... Please wait...

Coronavirus: COVID 19: To get in touch please email info@qualsafe.com. While our phone lines are still open, due to the current situation we will be able to answer emails more promptly.
The First Aid Quality Partnership (FAQP) has now made a statement and the First Aid Awarding Organisation Forum (FAAOF) have amended their previous statement, to provide joint FAQP/FAAOF guidance for first aid training during the COVID-19 pandemic. The joint statement is available here.

EpiPen Adrenaline Auto-Injector Shortages in the UK



People with severe allergies in the UK have been advised that they can continue to use their EpiPen auto-injector past its normal 12 month expiry date. This follows after an ongoing shortage of the life-saving devices across the UK, USA, Canada and Australia.

EpiPen is one of the most common types of adrenaline auto-injector and is prescribed to those who have allergies and are at risk of suffering a severe allergic reaction, commonly known as anaphylaxis. 

Medicines & Healthcare Products Regulatory Agency (MHRA) has agreed with the distributor of EpiPen, Mylan UK, to safely extend the use of a specific number of EpiPen 0.3mg auto-injectors beyond the labelled expiry date by four months. The MHRA stated that it made the decision after it was given evidence that showed the shelf life of the 0.3mg pen was 20 months from the date it was manufactured.

A list of affected lot numbers can be found listed below:

Anaphyaxis.JPG

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Please be aware that the extended use only applies to the EpiPen 0.3mg auto-injectors that have been listed above and does not apply to the 0.15mg version. The specific lots will continue to work safely and as intended within the extended use by date provided; however, at the end of this period, a new auto-injector will need to be obtained.

For more information on the availability of EpiPen, as well as Emerade and Jext, please visit the Anaphylaxis Campaign website by simply clicking here.